{
  "success": true,
  "pagesUsed": [
    1,
    8,
    11,
    19,
    21,
    23
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "PROTOCOL SYNOPSIS",
        "text": "PROTOCOL SYNOPSIS",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "0",
        "sectionTitle": "PROTOCOL SYNOPSIS",
        "sectionType": {
          "id": "712d9929-b6a5-41c2-9333-ac09392cbe77",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_2",
        "name": "STUDY SCHEMA",
        "text": "STUDY SCHEMA",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "0.1",
        "sectionTitle": "STUDY SCHEMA",
        "sectionType": {
          "id": "0b0bb5f1-4777-457f-97ff-1ab20b8675ff",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_3",
        "name": "OBJECTIVES",
        "text": "OBJECTIVES",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "OBJECTIVES",
        "sectionType": {
          "id": "ee298f2b-8f7e-4e03-81e4-eafc478d6479",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_3_1",
          "nci_3_2"
        ]
      },
      {
        "id": "nc_4",
        "name": "DISEASE BACKGROUND AND RATIONALE",
        "text": "DISEASE BACKGROUND AND RATIONALE",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "DISEASE BACKGROUND AND RATIONALE",
        "sectionType": {
          "id": "4b53da02-7518-48be-a169-fa8d6b98a902",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3",
          "nci_4_4",
          "nci_4_5"
        ]
      },
      {
        "id": "nc_5",
        "name": "STUDY DESIGN",
        "text": "STUDY DESIGN",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "STUDY DESIGN",
        "sectionType": {
          "id": "8e5c9e7c-1833-431a-b5ea-fc72eb455fc1",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_5_1",
          "nci_5_2",
          "nci_5_3",
          "nci_5_4",
          "nci_5_5"
        ]
      },
      {
        "id": "nc_6",
        "name": "SUBJECT SCREENING AND ENROLLMENT",
        "text": "SUBJECT SCREENING AND ENROLLMENT",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4",
        "sectionTitle": "SUBJECT SCREENING AND ENROLLMENT",
        "sectionType": {
          "id": "a6f90a94-b35f-4987-9c71-166ef83aa05a",
          "code": "Study Population",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Population",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_7",
        "name": "SUBJECT ELIGIBILITY",
        "text": "SUBJECT ELIGIBILITY",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "5",
        "sectionTitle": "SUBJECT ELIGIBILITY",
        "sectionType": {
          "id": "4bcfc6a5-297a-4c80-9a92-894a9535ac63",
          "code": "Eligibility Criteria",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Eligibility Criteria",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_7_1",
          "nci_7_2"
        ]
      },
      {
        "id": "nc_8",
        "name": "PROTOCOL TREATMENT",
        "text": "PROTOCOL TREATMENT",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "6",
        "sectionTitle": "PROTOCOL TREATMENT",
        "sectionType": {
          "id": "ce172643-aa50-494b-9878-90fb0d3adf7f",
          "code": "Treatment",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_8_1",
          "nci_8_2"
        ]
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_3_1",
        "name": "Primary Objective",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1",
        "sectionTitle": "Primary Objective"
      },
      {
        "id": "nci_3_2",
        "name": "Secondary Objectives",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2",
        "sectionTitle": "Secondary Objectives"
      },
      {
        "id": "nci_4_1",
        "name": "Standard First-line Therapy",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1",
        "sectionTitle": "Standard First-line Therapy"
      },
      {
        "id": "nci_4_2",
        "name": "Standard Second-line Therapy",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "Standard Second-line Therapy"
      },
      {
        "id": "nci_4_3",
        "name": "Study Rationale",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3",
        "sectionTitle": "Study Rationale"
      },
      {
        "id": "nci_4_4",
        "name": "Anti-CD19 Chimeric Antigen Receptor T Cells",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.4",
        "sectionTitle": "Anti-CD19 Chimeric Antigen Receptor T Cells"
      },
      {
        "id": "nci_4_5",
        "name": "Prior Anti-CD19 CAR T-cell Study Designs and Results",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.5",
        "sectionTitle": "Prior Anti-CD19 CAR T-cell Study Designs and Results"
      },
      {
        "id": "nci_5_1",
        "name": "General Study Design: ZUMA-7",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.1",
        "sectionTitle": "General Study Design: ZUMA-7"
      },
      {
        "id": "nci_5_2",
        "name": "Participating Sites",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.2",
        "sectionTitle": "Participating Sites"
      },
      {
        "id": "nci_5_3",
        "name": "Number of Subjects",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3",
        "sectionTitle": "Number of Subjects"
      },
      {
        "id": "nci_5_4",
        "name": "Replacement of Subjects",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.4",
        "sectionTitle": "Replacement of Subjects"
      },
      {
        "id": "nci_5_5",
        "name": "Duration of Study and Subject Participation",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.5",
        "sectionTitle": "Duration of Study and Subject Participation"
      },
      {
        "id": "nci_7_1",
        "name": "Inclusion Criteria",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.1",
        "sectionTitle": "Inclusion Criteria"
      },
      {
        "id": "nci_7_2",
        "name": "Exclusion Criteria",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.2",
        "sectionTitle": "Exclusion Criteria"
      },
      {
        "id": "nci_8_1",
        "name": "Treatment Terminology",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.1",
        "sectionTitle": "Treatment Terminology"
      },
      {
        "id": "nci_8_2",
        "name": "Axicabtagene Ciloleucel Study Treatment Arm",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.2",
        "sectionTitle": "Axicabtagene Ciloleucel Study Treatment Arm"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "AE",
        "expandedText": "Adverse event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "ALL",
        "expandedText": "Acute lymphoblastic leukemia",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "ALT",
        "expandedText": "Alanine aminotransferase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "ANC",
        "expandedText": "Absolute neutrophil count",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "ASCT",
        "expandedText": "Autologous stem cell transplant",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "AST",
        "expandedText": "Aspartate aminotransferase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "AUC",
        "expandedText": "Area under the curve",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "Axicabtagene ciloleucel",
        "expandedText": "Autologous T cells transduced with retroviral vector containing anti-CD19 CD28/CD3ζ chimeric antigen receptor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "CAR",
        "expandedText": "Chimeric antigen receptor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "CBC",
        "expandedText": "Complete blood count",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "CD",
        "expandedText": "cluster of differentiation",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "CI",
        "expandedText": "confidence interval",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "CLL",
        "expandedText": "Chronic lymphocytic leukemia",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "CMR",
        "expandedText": "Complete metabolic response",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_15",
        "abbreviatedText": "CNS",
        "expandedText": "Central nervous system",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_16",
        "abbreviatedText": "CR",
        "expandedText": "Complete response",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_17",
        "abbreviatedText": "CRF",
        "expandedText": "Case Report Form",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_18",
        "abbreviatedText": "CRP",
        "expandedText": "C-reactive protein",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_19",
        "abbreviatedText": "CRO",
        "expandedText": "Contract Research Organization",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_20",
        "abbreviatedText": "CRR",
        "expandedText": "Complete radiologic response",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_21",
        "abbreviatedText": "CRS",
        "expandedText": "Cytokine release syndrome",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_22",
        "abbreviatedText": "CSF",
        "expandedText": "Cerebrospinal fluid",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_23",
        "abbreviatedText": "CSR",
        "expandedText": "Clinical Study Report",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_24",
        "abbreviatedText": "CT",
        "expandedText": "Computed tomography",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_25",
        "abbreviatedText": "CTCAE",
        "expandedText": "Common Terminology Criteria for Adverse Events",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_26",
        "abbreviatedText": "DLBCL",
        "expandedText": "Diffuse large B-cell lymphoma",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_27",
        "abbreviatedText": "DOR",
        "expandedText": "Duration of response",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_28",
        "abbreviatedText": "DSMB",
        "expandedText": "Data Safety Monitoring Board",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_29",
        "abbreviatedText": "eCRF",
        "expandedText": "Electronic Case Report Form",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_30",
        "abbreviatedText": "ECG",
        "expandedText": "Electrocardiogram",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_31",
        "abbreviatedText": "ECHO",
        "expandedText": "Echocardiogram",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_32",
        "abbreviatedText": "ECOG",
        "expandedText": "Eastern Cooperative Oncology Group",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_33",
        "abbreviatedText": "EEG",
        "expandedText": "Electroencephalogram",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_34",
        "abbreviatedText": "EFS",
        "expandedText": "Event-free survival",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_35",
        "abbreviatedText": "EORTC QLQ-C30",
        "expandedText": "European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Cancer-30 (QLQ-C30)",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_36",
        "abbreviatedText": "EQ-5D-5L",
        "expandedText": "Euro-QOL, Five Dimensions, Five Levels",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_37",
        "abbreviatedText": "FAS",
        "expandedText": "Full analysis set",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_38",
        "abbreviatedText": "HDT",
        "expandedText": "high-dose therapy",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_39",
        "abbreviatedText": "IB",
        "expandedText": "Investigator’s Brochure",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_40",
        "abbreviatedText": "IPI",
        "expandedText": "International Prognostic Index",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_41",
        "abbreviatedText": "LTR",
        "expandedText": "long terminal repeat",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_42",
        "abbreviatedText": "NCI",
        "expandedText": "National Cancer Institute",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_43",
        "abbreviatedText": "NHL",
        "expandedText": "non-Hodgkin lymphoma",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_44",
        "abbreviatedText": "ORR",
        "expandedText": "objective response rate",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_45",
        "abbreviatedText": "PMBCL",
        "expandedText": "primary mediastinal B-cell lymphoma",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_46",
        "abbreviatedText": "PR",
        "expandedText": "partial response",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_47",
        "abbreviatedText": "r/r DLBCL",
        "expandedText": "relapsed/refractory diffuse large B-cell lymphoma",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_48",
        "abbreviatedText": "scFv",
        "expandedText": "single-chain variable fragment",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_49",
        "abbreviatedText": "SOA",
        "expandedText": "schedule of assessments",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_50",
        "abbreviatedText": "SOC",
        "expandedText": "standard of care therapy",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_51",
        "abbreviatedText": "TFL",
        "expandedText": "transformed follicular lymphoma",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_52",
        "abbreviatedText": "WBC",
        "expandedText": "white blood count",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 8,
      "itemCount": 16,
      "abbreviationCount": 52
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel versus Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "Amendment 6",
      "versionDate": "14 April 2023",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "AE",
          "expansion": "Adverse event"
        },
        {
          "abbreviation": "ALL",
          "expansion": "Acute lymphoblastic leukemia"
        },
        {
          "abbreviation": "ALT",
          "expansion": "Alanine aminotransferase"
        },
        {
          "abbreviation": "ANC",
          "expansion": "Absolute neutrophil count"
        },
        {
          "abbreviation": "ASCT",
          "expansion": "Autologous stem cell transplant"
        },
        {
          "abbreviation": "AST",
          "expansion": "Aspartate aminotransferase"
        },
        {
          "abbreviation": "AUC",
          "expansion": "Area under the curve"
        },
        {
          "abbreviation": "Axicabtagene ciloleucel",
          "expansion": "Autologous T cells transduced with retroviral vector containing anti-CD19 CD28/CD3ζ chimeric antigen receptor"
        },
        {
          "abbreviation": "CAR",
          "expansion": "Chimeric antigen receptor"
        },
        {
          "abbreviation": "CBC",
          "expansion": "Complete blood count"
        },
        {
          "abbreviation": "CD",
          "expansion": "cluster of differentiation"
        },
        {
          "abbreviation": "CI",
          "expansion": "confidence interval"
        },
        {
          "abbreviation": "CLL",
          "expansion": "Chronic lymphocytic leukemia"
        },
        {
          "abbreviation": "CMR",
          "expansion": "Complete metabolic response"
        },
        {
          "abbreviation": "CNS",
          "expansion": "Central nervous system"
        },
        {
          "abbreviation": "CR",
          "expansion": "Complete response"
        },
        {
          "abbreviation": "CRF",
          "expansion": "Case Report Form"
        },
        {
          "abbreviation": "CRP",
          "expansion": "C-reactive protein"
        },
        {
          "abbreviation": "CRO",
          "expansion": "Contract Research Organization"
        },
        {
          "abbreviation": "CRR",
          "expansion": "Complete radiologic response"
        },
        {
          "abbreviation": "CRS",
          "expansion": "Cytokine release syndrome"
        },
        {
          "abbreviation": "CSF",
          "expansion": "Cerebrospinal fluid"
        },
        {
          "abbreviation": "CSR",
          "expansion": "Clinical Study Report"
        },
        {
          "abbreviation": "CT",
          "expansion": "Computed tomography"
        },
        {
          "abbreviation": "CTCAE",
          "expansion": "Common Terminology Criteria for Adverse Events"
        },
        {
          "abbreviation": "DLBCL",
          "expansion": "Diffuse large B-cell lymphoma"
        },
        {
          "abbreviation": "DOR",
          "expansion": "Duration of response"
        },
        {
          "abbreviation": "DSMB",
          "expansion": "Data Safety Monitoring Board"
        },
        {
          "abbreviation": "eCRF",
          "expansion": "Electronic Case Report Form"
        },
        {
          "abbreviation": "ECG",
          "expansion": "Electrocardiogram"
        },
        {
          "abbreviation": "ECHO",
          "expansion": "Echocardiogram"
        },
        {
          "abbreviation": "ECOG",
          "expansion": "Eastern Cooperative Oncology Group"
        },
        {
          "abbreviation": "EEG",
          "expansion": "Electroencephalogram"
        },
        {
          "abbreviation": "EFS",
          "expansion": "Event-free survival"
        },
        {
          "abbreviation": "EORTC QLQ-C30",
          "expansion": "European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Cancer-30 (QLQ-C30)"
        },
        {
          "abbreviation": "EQ-5D-5L",
          "expansion": "Euro-QOL, Five Dimensions, Five Levels"
        },
        {
          "abbreviation": "FAS",
          "expansion": "Full analysis set"
        },
        {
          "abbreviation": "HDT",
          "expansion": "high-dose therapy"
        },
        {
          "abbreviation": "IB",
          "expansion": "Investigator’s Brochure"
        },
        {
          "abbreviation": "IPI",
          "expansion": "International Prognostic Index"
        },
        {
          "abbreviation": "LTR",
          "expansion": "long terminal repeat"
        },
        {
          "abbreviation": "NCI",
          "expansion": "National Cancer Institute"
        },
        {
          "abbreviation": "NHL",
          "expansion": "non-Hodgkin lymphoma"
        },
        {
          "abbreviation": "ORR",
          "expansion": "objective response rate"
        },
        {
          "abbreviation": "PMBCL",
          "expansion": "primary mediastinal B-cell lymphoma"
        },
        {
          "abbreviation": "PR",
          "expansion": "partial response"
        },
        {
          "abbreviation": "r/r DLBCL",
          "expansion": "relapsed/refractory diffuse large B-cell lymphoma"
        },
        {
          "abbreviation": "scFv",
          "expansion": "single-chain variable fragment"
        },
        {
          "abbreviation": "SOA",
          "expansion": "schedule of assessments"
        },
        {
          "abbreviation": "SOC",
          "expansion": "standard of care therapy"
        },
        {
          "abbreviation": "TFL",
          "expansion": "transformed follicular lymphoma"
        },
        {
          "abbreviation": "WBC",
          "expansion": "white blood count"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel versus Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7)",
        "version": "Amendment 6",
        "versionDate": "14 April 2023"
      },
      "sections": [
        {
          "number": "0",
          "title": "PROTOCOL SYNOPSIS",
          "type": "Synopsis"
        },
        {
          "number": "0.1",
          "title": "STUDY SCHEMA",
          "type": "Study Design"
        },
        {
          "number": "1",
          "title": "OBJECTIVES",
          "type": "Objectives",
          "subsections": [
            {
              "number": "1.1",
              "title": "Primary Objective"
            },
            {
              "number": "1.2",
              "title": "Secondary Objectives"
            }
          ]
        },
        {
          "number": "2",
          "title": "DISEASE BACKGROUND AND RATIONALE",
          "type": "Introduction",
          "subsections": [
            {
              "number": "2.1",
              "title": "Standard First-line Therapy"
            },
            {
              "number": "2.2",
              "title": "Standard Second-line Therapy"
            },
            {
              "number": "2.3",
              "title": "Study Rationale"
            },
            {
              "number": "2.4",
              "title": "Anti-CD19 Chimeric Antigen Receptor T Cells"
            },
            {
              "number": "2.5",
              "title": "Prior Anti-CD19 CAR T-cell Study Designs and Results"
            }
          ]
        },
        {
          "number": "3",
          "title": "STUDY DESIGN",
          "type": "Study Design",
          "subsections": [
            {
              "number": "3.1",
              "title": "General Study Design: ZUMA-7"
            },
            {
              "number": "3.2",
              "title": "Participating Sites"
            },
            {
              "number": "3.3",
              "title": "Number of Subjects"
            },
            {
              "number": "3.4",
              "title": "Replacement of Subjects"
            },
            {
              "number": "3.5",
              "title": "Duration of Study and Subject Participation"
            }
          ]
        },
        {
          "number": "4",
          "title": "SUBJECT SCREENING AND ENROLLMENT",
          "type": "Study Population"
        },
        {
          "number": "5",
          "title": "SUBJECT ELIGIBILITY",
          "type": "Eligibility Criteria",
          "subsections": [
            {
              "number": "5.1",
              "title": "Inclusion Criteria"
            },
            {
              "number": "5.2",
              "title": "Exclusion Criteria"
            }
          ]
        },
        {
          "number": "6",
          "title": "PROTOCOL TREATMENT",
          "type": "Treatment",
          "subsections": [
            {
              "number": "6.1",
              "title": "Treatment Terminology"
            },
            {
              "number": "6.2",
              "title": "Axicabtagene Ciloleucel Study Treatment Arm"
            }
          ]
        }
      ]
    }
  }
}